A citation-based method for searching scientific literature

List of co-cited articles
1294 articles co-cited >1

Times Cited
  Times     Co-cited

NF-kappaB in cancer: from innocent bystander to major culprit.
Michael Karin, Yixue Cao, Florian R Greten, Zhi-Wei Li. Nat Rev Cancer 2002

Signaling to NF-kappaB.
Matthew S Hayden, Sankar Ghosh. Genes Dev 2004

The c-Rel transcription factor and B-cell proliferation: a deal with the devil.
Thomas D Gilmore, Demetrios Kalaitzidis, Mei-Chih Liang, Daniel T Starczynowski. Oncogene 2004

IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer.
Florian R Greten, Lars Eckmann, Tim F Greten, Jin Mo Park, Zhi-Wei Li, Laurence J Egan, Martin F Kagnoff, Michael Karin. Cell 2004

NF-kappaB functions as a tumour promoter in inflammation-associated cancer.
Eli Pikarsky, Rinnat M Porat, Ilan Stein, Rinat Abramovitch, Sharon Amit, Shafika Kasem, Elena Gutkovich-Pyest, Simcha Urieli-Shoval, Eithan Galun, Yinon Ben-Neriah. Nature 2004

REL proto-oncogene is frequently amplified in extranodal diffuse large cell lymphoma.
J Houldsworth, S Mathew, P H Rao, K Dyomina, D C Louie, N Parsa, K Offit, R S Chaganti. Blood 1996

Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway.
U Senftleben, Y Cao, G Xiao, F R Greten, G Krähn, G Bonizzi, Y Chen, Y Hu, A Fong, S C Sun,[...]. Science 2001

NF-kappaB at the crossroads of life and death.
Michael Karin, Anning Lin. Nat Immunol 2002

Missing pieces in the NF-kappaB puzzle.
Sankar Ghosh, Michael Karin. Cell 2002

Gains of 2p involving the REL locus correlate with nuclear c-Rel protein accumulation in neoplastic cells of classical Hodgkin lymphoma.
Thomas F E Barth, Josée I Martin-Subero, Stefan Joos, Christiane K Menz, Cornelia Hasel, Gunhild Mechtersheimer, Reza M Parwaresch, Peter Lichter, Reiner Siebert, Peter Möoller. Blood 2003

Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells.
R C Bargou, F Emmerich, D Krappmann, K Bommert, M Y Mapara, W Arnold, H D Royer, E Grinstein, A Greiner, C Scheidereit,[...]. J Clin Invest 1997

Malignant transformation of primary chicken spleen cells by human transcription factor c-Rel.
T D Gilmore, C Cormier, J Jean-Jacques, M E Gapuzan. Oncogene 2001

Mouse mammary tumor virus c-rel transgenic mice develop mammary tumors.
Raphaëlle Romieu-Mourez, Dong W Kim, Sang Min Shin, Elizabeth G Demicco, Esther Landesman-Bollag, David C Seldin, Robert D Cardiff, Gail E Sonenshein. Mol Cell Biol 2003

The human B-cell lymphoma cell line RC-K8 has multiple genetic alterations that dysregulate the Rel/NF-kappaB signal transduction pathway.
Demetrios Kalaitzidis, R Eric Davis, Andreas Rosenwald, Louis M Staudt, Thomas D Gilmore. Oncogene 2002

NF-kappaB regulation in the immune system.
Qiutang Li, Inder M Verma. Nat Rev Immunol 2002

NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1.
D C Guttridge, C Albanese, J Y Reuther, R G Pestell, A S Baldwin. Mol Cell Biol 1999

The IKKbeta subunit of IkappaB kinase (IKK) is essential for nuclear factor kappaB activation and prevention of apoptosis.
Z W Li, W Chu, Y Hu, M Delhase, T Deerinck, M Ellisman, R Johnson, M Karin. J Exp Med 1999

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling.
A A Alizadeh, M B Eisen, R E Davis, C Ma, I S Lossos, A Rosenwald, J C Boldrick, H Sabet, T Tran, X Yu,[...]. Nature 2000

A requirement for NF-kappaB activation in Bcr-Abl-mediated transformation.
J Y Reuther, G W Reuther, D Cortez, A M Pendergast, A S Baldwin. Genes Dev 1998

NF-kappaB function in growth control: regulation of cyclin D1 expression and G0/G1-to-S-phase transition.
M Hinz, D Krappmann, A Eichten, A Heder, C Scheidereit, M Strauss. Mol Cell Biol 1999

B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-kappa B p50.
A Neri, C C Chang, L Lombardi, M Salina, P Corradini, A T Maiolo, R S Chaganti, R Dalla-Favera. Cell 1991

Molecular mechanisms of constitutive NF-kappaB/Rel activation in Hodgkin/Reed-Sternberg cells.
D Krappmann, F Emmerich, U Kordes, E Scharschmidt, B Dörken, C Scheidereit. Oncogene 1999

Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer.
M A Sovak, R E Bellas, D W Kim, G J Zanieski, A E Rogers, A M Traish, G E Sonenshein. J Clin Invest 1997

Retroviral oncoprotein Tax induces processing of NF-kappaB2/p100 in T cells: evidence for the involvement of IKKalpha.
G Xiao, M E Cvijic, A Fong, E W Harhaj, M T Uhlik, M Waterfield, S C Sun. EMBO J 2001

Primary mediastinal (thymic) B-cell lymphoma is characterized by gains of chromosomal material including 9p and amplification of the REL gene.
S Joos, M I Otaño-Joos, S Ziegler, S Brüderlein, S du Manoir, M Bentz, P Möller, P Lichter. Blood 1996

Chromosomal and gene amplification in diffuse large B-cell lymphoma.
P H Rao, J Houldsworth, K Dyomina, N Z Parsa, J C Cigudosa, D C Louie, L Popplewell, K Offit, S C Jhanwar, R S Chaganti. Blood 1998

The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-kappaB pathways.
Emmanuel Dejardin, Nathalie M Droin, Mireille Delhase, Elvira Haas, Yixue Cao, Constantin Makris, Zhi-Wei Li, Michael Karin, Carl F Ware, Douglas R Green. Immunity 2002

Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B.
A A Beg, W C Sha, R T Bronson, S Ghosh, D Baltimore. Nature 1995

NF-kappaB blockade and oncogenic Ras trigger invasive human epidermal neoplasia.
Maya Dajee, Mirella Lazarov, Jennifer Y Zhang, Ti Cai, Cheryl L Green, Alan J Russell, M Peter Marinkovich, Shiying Tao, Qun Lin, Yoshiaki Kubo,[...]. Nature 2003

Sulindac inhibits activation of the NF-kappaB pathway.
Y Yamamoto, M J Yin, K M Lin, R B Gaynor. J Biol Chem 1999

Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.